Substituted heterocycles for targeting Hsp90

US10927115B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10927115-B2
Application numberUS-201916550715-A
CountryUS
Kind codeB2
Filing dateAug 26, 2019
Priority dateAug 6, 2012
Publication dateFeb 23, 2021
Grant dateFeb 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Substituted indazoles linked to a substituted adenine with a polyethylene glycol moiety selectively bind to Hsp90. The compounds include detection moieties such as fluorophores and are useful in methods and kits for selective detection of Hsp90 in a sample.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I): wherein: A is formula (II): wherein: X is CR 9 or N; Y is CR 3 or N; R 1 is H or C 1-8 -alkyl; R 2 is H or C 1-8 -alkyl; R 3 is H, F, or OCH 3 ; R 4 is H, F, or OCH 3 ; R 5 is H, F, or OCH 3 ; R 6 is C 1-8 -alkyl, halo-C 1-8 -alkyl, hydroxy-C 1-8 -alkyl, C 3-8 -cycloalkyl-C 1-8 -alkyl, C 3-8 -cycloalkenyl-C 1-8 -alkyl, heterocyclyl-C 1-8 -alkyl, aryl-C 1-8 -alkyl, heteroaryl-C 1-8 -alkyl, C 2-8 -alkenyl, C 2-8 -alkynyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkenyl, heterocyclyl, aryl, or heteroaryl; R 7 is H or C 1-8 -alkyl; R 8 is H or C 1-8 -alkyl; or R 7 and R 8 , taken together with the carbon atom to which they are attached, form a C 3-8 -cycloalkyl; R 9 is H or C 1-8 -alkyl; and is the point of attachment in formula (I); X 1 is —C(O)—, —NH—, —O—, —S—, or —S(O) 2 —; L is a divalent linker of the following formula: —(CH 2 ) m —(OCH 2 CH 2 ) n —O—(CH 2 ) p —, wherein: m is 2 or 3; n is 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20; and p is 2 or 3; X 2 is —NR—; R is a detection moiety; and B is formula (III): wherein: R is alkylenyl or heteroalkylenyl; each Y 1 is independently CH or N; each Z 1 , taken together with the carbon atoms to which they are attached, form a heterocyclyl; Z 2 is H or halo; Z 3 is —CH 2 —, —NH—, —O—, or —S—; Z 4 is H or halo; and is the point of attachment in formula (I); wherein the detection moiety comprises a fluorophore or a radioactive compound; wherein the fluorophore is a fluorescein, a rhodamine, a coumarin, a cyanine, or a boron-dipyrromethene; and wherein the radioactive compound is a radioisotope. 2. The compound of claim 1 , wherein: X is N; Y is CR 3 ; R 1 is H; R 2 is H; R 3 is H; R 4 is H; R 5 is H; R 6 is C 1-8 -alkyl or halo-C 1-8 -alkyl; R 7 is C 1-8 -alkyl; and R 8 is C 1-8 -alkyl. 3. The compound of claim 1 , wherein A is: 4. The compound of claim 1 , wherein: m is 3; and p is 3. 5. The compound of claim 1 , wherein n is 4. 6. The compound of claim 1 , wherein the detection moiety comprises a fluorophore. 7. The compound of claim 6 , wherein the fluorophore is a fluorescein. 8. The compound of claim 6 , wherein the detection moiety is: 9. The compound of claim 1 , wherein B is: 10. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier. 11. A kit comprising a compound of claim 1 . 12. A method for detecting heat shock protein 90 in a sample, wherein the method comprises the following steps: a) contacting the sample with the compound of claim 1 ; and b) detecting a signal from the detection moiety. 13. A method for detecting cancer in a subject, wherein the method comprises the following steps: a) contacting a biological sample from the subject with the compound of claim 1 ; and b) detecting a signal from the detection moiety. 14. A method for detecting human immunodeficiency virus in a subject, wherein the method comprises the following steps: a) contacting a biological sample from the subject with the compound of claim 1 ; and b) detecting a signal from the detection moiety.

Assignees

Inventors

Classifications

  • involving intracellular compounds · CPC title

  • for cancer · CPC title

  • C07D231/54Primary

    condensed with carbocyclic rings or ring systems · CPC title

  • C07D473/34Primary

    attached in position 6, e.g. adenine · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10927115B2 cover?
Substituted indazoles linked to a substituted adenine with a polyethylene glycol moiety selectively bind to Hsp90. The compounds include detection moieties such as fluorophores and are useful in methods and kits for selective detection of Hsp90 in a sample.
Who is the assignee on this patent?
Univ Duke
What technology area does this patent fall under?
Primary CPC classification C07D231/54. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).